Sign in

Yazan J. Meqbil

@yazmeq.bsky.social
662 followers 146 following 13 posts

Molecular Pharmacologist automating the intersections of HTS, computational modeling, and molecular pharmacology | Pasadena, CA

PostsRepliesMedia
Reposted by Yazan J. Meqbil
Bryan Roth @zenbrainest.bsky.social · 12/05/2025
Must read! Intracellular GPCR modulators enable precision pharmacology www.nature.com/articles/s44...
nature.com
Intracellular GPCR modulators enable precision pharmacology - npj Drug Discovery
npj Drug Discovery - Intracellular GPCR modulators enable precision pharmacology
02114
Reposted by Yazan J. Meqbil
Dr. Sven-Eric Jordt #TobRegSky @sejordt.bsky.social · 11/05/2025
#TobRegSky #PedSky #MedSky #addictionsci #neuroskyence #neurosci #policysky #polisky #painresearch 🧪🛟
192
Yazan J. Meqbil @yazmeq.bsky.social · 10/05/2025
Amazing indeed! This method tracks single molecules escaping nanoscale traps to reveal size, shape, and conformational states in solution. Hats off to the authors for an outstanding advancement.
010
Reposted by Yazan J. Meqbil
Joshua Kugel @joshkugel.bsky.social · 28/04/2025
The first paper from my PhD has been published! Insights on Psychedelics: A Systematic Review of Therapeutic Effects www.sciencedirect.com/science/arti...
sciencedirect.com
Insights on psychedelics: A systematic review of therapeutic effects
Insight – a sudden change in understanding or perspective that feels true or reliable – is a common occurrence during psychedelic experiences, and oft…
1224
Yazan J. Meqbil @yazmeq.bsky.social · 21/11/2024
Exciting news from our team here at Vilya! RFpeptides is an RFdiffusion-based DL pipeline for designing macrocyclic peptides. Exclusively licensed to Vilya🔥 It’s an exciting time to at the forefront of the macrocyclic peptide drug discovery space. Preprint: www.biorxiv.org/content/10.1...
biorxiv.org
Accurate de novo design of high-affinity protein binding macrocycles using deep learning
The development of macrocyclic binders to therapeutic proteins typically relies on large-scale screening methods that are resource-intensive and provide little control over binding mode. Despite consi...
020
Yazan J. Meqbil @yazmeq.bsky.social · 21/11/2024
Congrats @tastelabhuji.bsky.social and team!
052
Yazan J. Meqbil @yazmeq.bsky.social · 21/11/2024
Another day, another excellent database. I’ve been an avid and grateful user of GPCRdb, GPCRmd, and other databases, all of which keep getting better. I’m excited to try this one! academic.oup.com/nar/advance-...
academic.oup.com
PGxDB: an interactive web-platform for pharmacogenomics research
Abstract. Pharmacogenomics, the study of how an individual's genetic makeup influences their response to medications, is a rapidly evolving field with sign
163
Reposted by Yazan J. Meqbil
Cornelius Gati @gati.bsky.social · 20/11/2024
This is amazing! @shervinnia.bsky.social resurrected our cryoEM-papers bot. At it's peak we had over 12k followers on Twitter, but the bot became defunct by a silly Musk policy (and it all went downhill from there). If you want to keep up with #cryoEM papers, follow: cryoempapers.bsky.social
cryoempapers.bsky.social
cryoEM papers (@cryoempapers.bsky.social)
Operated by @shervinnia.bsky.social and inspired by the now-defunct bot by Frédéric Poitevin and @gati.bsky.social. Suggestions welcome.
12811
Yazan J. Meqbil @yazmeq.bsky.social · 20/11/2024
Another paper from the Van Rijn and Riley labs on natural product-derived agonists for the kappa opioid receptors. pubs.acs.org/doi/10.1021/...
pubs.acs.org
Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine
Akuammicine (1), an alkaloid isolated from Picralima nitida, is an agonist of the kappa opioid receptor (κOR). To establish structure–activity relationships (SARs) for this structurally unique κOR lig...
042
Reposted by Yazan J. Meqbil
Cornelius Gati @gati.bsky.social · 16/11/2024
A first attempt to assemble GPCR aficionados here on 🦋 Let me know who I missed by replying below! go.bsky.app/75ukb81
223722
Yazan J. Meqbil @yazmeq.bsky.social · 16/11/2024
It feels so good to be back! #sci-twitter was good but I hope #sci-sky will be better! #science #gpcr #drugdiscovery
040